Models built by using artificial intelligence (AI) to annotate clinical reports from more ... whereas others rapidly progress, colonizing the brain or liver. Tumour-genome profiling and digitized ...
AIM ImmunoTech Inc. announced progress in its clinical development of Ampligen® (rintatolimod), particularly in addressing critical unmet medical needs in areas like pancreatic cancer and Long-COVID.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback